×
0 0 0 0 0 0 0 0.0305232558139535
Stockreport

Translate Bio to Present Preclinical Data Supporting MRT5005 at the 32nd Annual North American Cystic Fibrosis Conference

Translate Bio, Inc (TBIO)  More Company Research Source: GlobeNewswire
PDF -- Findings support ongoing Phase 1/2 study of once-weekly nebulized MRT5005 in adults with cystic fibrosis -- LEXINGTON, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Translate Bio, Inc. (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, today announced the presentation of preclinical data for MRT5005, a first-in-class mRNA therapeutic designed to treat all patients with cystic fibrosis regardless of mutation. The presentation includes data demonstrating that MRT5005 was efficiently delivered to the lungs of rodents and non-human primates by nebulization, resulting in functional cystic fibrosis transmembrane conductance regulator (CFTR) protein expression. These data will be featured in a poster presentation at the 32nd Annual North American Cystic Fibrosis Conference (NACFC) taking place in Denver, Colorado, from October 18-20, 2018. “MRT5005 [Read more]

IMPACT SNAPSHOT EVENT TIME: TBIO
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
TBIO alerts
from News Quantified
Opt-in for
TBIO alerts

from News Quantified
Opt-in for
TBIO alerts

from News Quantified